Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment, according to a University of Southampton study published in Nature Immunotherapy. Christian Ottensmeier, Professor of Experimental Medicine at the University said: “These are hugely exciting results. For the first time we have a real indication of who might benefit from a particular drug before we make treatment decisions.
Copy and paste this URL into your WordPress site to embed
